New Product: Tekamlo™, a Combination of Aliskiren and Amlodipine

Tekamlo™, a Combination of Aliskiren and Amlodipine

Novartis Receives FDA Approval of Tekamlo™, a Combination of Aliskiren and Amlodipine to Treat High Blood Pressure: Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone. Novartis Press Release